Evidence map›Paper›PMID 20577145›Full record

ArticleShock (Augusta, Ga.)2011

Macrophage-produced IL-12p70 mediates hemorrhage-induced damage in a complement-dependent manner.

Diana J Hylton, Sara M Hoffman, N Van Rooijen, Stephen Tomlinson, Sherry D Fleming

Open access · greenAbstract read
In one paragraph

Article in Shock (Augusta, Ga.), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Tissue-targeted complement therapeutics.Molecular immunology · 2018
    Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Diana J HyltonDivision of Biology, Kansas State University, Manhattan, KS 66506, USA.
Sara M Hoffman
N Van Rooijen
Stephen Tomlinson
Sherry D Fleming
Kansas State University · USMedical University of South Carolina · USVrije Universiteit Amsterdam · NL

Funding

UNDERSTANDING THE ROLE OF SMALL RNAS IN ARABIDOPSIS POLLEN DEVELOPMENTP20RR016475 · NCRR · UNIVERSITY OF KANSAS MEDICAL CENTER · PI ACKLEY, BRIAN DOUGLAS · 2001 to 2011
$38.1M
TRANSEPITHELIAL ION TRANSPORT &ITS REGULATIONP20RR017686 · NCRR · KANSAS STATE UNIVERSITY · PI MELGAREJO GARCIA, LUIS TONATIUH · 2002 to 2011
$21.8M
Natural Antibodies and Tissue InjuryR01AI061691 · NIAID · KANSAS STATE UNIVERSITY · PI FLEMING, SHERRY · 2007 to 2011
$1.7M
NCRR NIH HHS P20 RR016475NCRR NIH HHS P20 RR017686NCRR NIH HHS RR016475NIAID NIH HHS AI061691NIAID NIH HHS R01 AI061691
6 · The paper itself

Abstract

Hemorrhage and hemorrhagic shock instigate intestinal damage and inflammation. Multiple components of the innate immune response, including complement and neutrophil infiltration, are implicated in this pathology. To investigate the interaction of complement activation and other components of the innate immune response during hemorrhage, we treated mice after hemorrhage with CR2-fH, a targeted inhibitor of the alternative complement pathway and assessed intestinal damage and inflammation 2 h after hemorrhage. In wild-type mice, CR2-fH attenuated hemorrhage-induced, midjejunal damage and inflammation as determined by decreased mucosal damage, macrophage infiltration, leukotriene B4, IL-12p40, and TNF-[alpha] production. The critical nature of intestinal macrophage infiltration and activation in the response to hemorrhage was further determined using mice pretreated with clodronate-containing liposomes. The absence of either macrophages or IL-12p70 attenuated intestinal damage. These data suggest that complement activation and macrophage infiltration with IL-12p70 production are critical to hemorrhage-induced midjejunal damage and inflammation.

Indexed as

AnimalsBone Density Conservation AgentsClodronic AcidComplement ActivationComplement Inactivating AgentsComplement System ProteinsImmunity, InnateInterleukin-12Intestinal DiseasesIntestinal MucosaIntestinesLeukotriene B4Macrophage ActivationMacrophagesMiceMice, KnockoutBone Density Conservation AgentsClodronic AcidComplement Inactivating AgentsComplement System ProteinsInterleukin-12Leukotriene B4Tumor Necrosis Factor-alpha

Identifiers

PMID20577145
PMCPMC3034979
OpenAlexW2093654903

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.